GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CeriBell Inc (NAS:CBLL) » Definitions » Change In Payables And Accrued Expense

CBLL (CeriBell) Change In Payables And Accrued Expense : $2.84 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is CeriBell Change In Payables And Accrued Expense?

CeriBell's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was $-1.42 Mil. It means CeriBell's Accounts Payable & Accrued Expense declined by $1.42 Mil from Dec. 2024 to Mar. 2025 .

CeriBell's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was $2.72 Mil. It means CeriBell's Accounts Payable & Accrued Expense increased by $2.72 Mil from Dec. 2023 to Dec. 2024 .


CeriBell Change In Payables And Accrued Expense Historical Data

The historical data trend for CeriBell's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CeriBell Change In Payables And Accrued Expense Chart

CeriBell Annual Data
Trend Dec22 Dec23 Dec24
Change In Payables And Accrued Expense
2.12 2.48 2.72

CeriBell Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Payables And Accrued Expense Get a 7-Day Free Trial -1.54 0.42 2.78 1.06 -1.42

CeriBell Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.84 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CeriBell Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of CeriBell's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


CeriBell Business Description

Industry
Traded in Other Exchanges
N/A
Address
360 N. Pastoria Avenue, Sunnyvale, CA, USA, 94085
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.